RDHL · RedHill Biopharma Ltd. · Documents
Market Cap
$3.75M
Shares
8.89M
Volume · Oct 23
105.52K
Avg daily vol (3M)
2.04M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2024-06-03 | — | |
| 6-K | — | 2024-05-06 | — | |
| 6-K | — | 2024-04-24 | — | |
| 20-F | — | 2024-04-08 | 2023-12-31 | |
| 6-K | — | 2024-04-08 | — | |
| 6-K | — | 2024-04-04 | — | |
| 6-K | — | 2024-04-03 | — | |
| 6-K | — | 2024-04-02 | — | |
| 6-K | — | 2024-03-21 | — | |
| 6-K | — | 2024-03-20 | — | |
| 6-K | — | 2024-03-14 | — | |
| 6-K | — | 2024-03-11 | — | |
| 6-K | — | 2024-03-05 | — | |
| 6-K | — | 2024-02-20 | — | |
| 6-K | — | 2024-02-20 | — | |
| 6-K | — | 2024-02-13 | — | |
| F-1 | — | 2024-02-09 | — | |
| 6-K | — | 2024-01-26 | — | |
| 6-K | — | 2024-01-26 | — | |
| 6-K | — | 2024-01-25 | — | |
| 6-K | — | 2024-01-25 | — | |
| 6-K | — | 2023-12-20 | — | |
| 6-K | — | 2023-12-12 | — | |
| 6-K | — | 2023-12-06 | — | |
| 6-K | — | 2023-12-04 | — | |
| 6-K | — | 2023-12-01 | — | |
| 6-K | — | 2023-11-27 | — | |
| 6-K | — | 2023-11-16 | — | |
| 6-K | — | 2023-11-14 | — | |
| F-3/A | — | 2023-10-23 | — | |
| 6-K | — | 2023-10-16 | — | |
| F-3 | — | 2023-10-13 | — | |
| 6-K | — | 2023-10-10 | — | |
| 6-K | — | 2023-10-03 | — | |
| 6-K | — | 2023-09-29 | — | |
| 6-K | — | 2023-09-22 | — | |
| 6-K | — | 2023-09-18 | — | |
| 6-K | — | 2023-09-05 | — | |
| 6-K | — | 2023-08-17 | 2023-06-30 | |
| 6-K | — | 2023-08-09 | — | |
| 6-K | — | 2023-08-08 | — | |
| F-3 | — | 2023-08-04 | — | |
| 6-K | — | 2023-08-01 | — | |
| 6-K | — | 2023-07-31 | — | |
| 6-K | — | 2023-07-25 | — | |
| 6-K | — | 2023-07-25 | — | |
| 6-K | — | 2023-07-21 | — | |
| 6-K | — | 2023-07-21 | — | |
| 6-K | — | 2023-07-06 | — | |
| 6-K | — | 2023-06-29 | — |
Showing 101–150 of 382 filings